Pretreatment with P2Y(12) Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported?

Excessive platelet reactivity plays a pivotal role in the pathogenesis of acute myocardial infarction. Today, the vast majority of patients presenting with acute coronary syndromes qualify for invasive treatment strategy and thus require fast and efficient platelet inhibition. Since 2008, in cases o...

Descripción completa

Detalles Bibliográficos
Autores principales: Niezgoda, Piotr, Ostrowska, Małgorzata, Adamski, Piotr, Gajda, Robert, Kubica, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054246/
https://www.ncbi.nlm.nih.gov/pubmed/36983373
http://dx.doi.org/10.3390/jcm12062374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054246/
https://www.ncbi.nlm.nih.gov/pubmed/36983373
http://dx.doi.org/10.3390/jcm12062374

Ejemplares similares